Hypoglycaemia: the Whipple triad, insulin and C-peptide
- Diagnostic approach
A low blood sugar can cause confusion, seizures and death. With diabetes, treatment is usually the cause; without it, a test taken during the low finds it.
See it in 3D: Pancreas
What it is
In people treated for diabetes, hypoglycaemia is almost always caused by insulin or insulin secretagogues (sulfonylureas, meglitinides), with a missed meal, exercise, alcohol or falling kidney function as triggers. In people without diabetes, hypoglycaemia is first proven by the Whipple triad: symptoms, a low plasma glucose (below about 55 mg/dL, 3.0 mmol/L) measured at the time, and relief when glucose is raised. Then a «critical sample» taken during the low (insulin, C-peptide, proinsulin, beta-hydroxybutyrate and a screen for secretagogues) shows the mechanism. In ill patients the usual causes are drugs, sepsis, liver or kidney failure, adrenal insufficiency, starvation and tumours that make IGF-2; in seemingly well people, insulinoma, hypoglycaemia after bariatric surgery, insulin autoimmunity and covert use of insulin or sulfonylureas.
What to know
- In diabetes care: level 1 is glucose below 70 mg/dL, level 2 below 54 mg/dL, and level 3 is any episode that needs another person's help.
- Warning symptoms (adrenergic and cholinergic): tremor, palpitations, sweating, hunger, anxiety. Brain-glucose symptoms: confusion, odd behaviour, seizures, coma.
- Repeated episodes blunt the warning symptoms (hypoglycaemia unawareness); weeks without hypoglycaemia can restore them.
- Sulfonylurea hypoglycaemia is prolonged and recurs, especially in older people and kidney failure.
- Beta-blockers blunt tremor and palpitations, but sweating remains.
- Insulinoma: fasting or exercise-induced lows, often with weight gain; small and usually benign; part of MEN1 in some patients.
- After gastric bypass, lows occur one to three hours after meals.
Step-by-step approach
- Treat first: fast-acting oral glucose if the patient can swallow; intravenous dextrose or glucagon if not.
- In a patient with diabetes, find the reason: drug or dose, missed meal, exercise, alcohol, kidney function, new interacting drugs.
- In a patient without diabetes, document the Whipple triad with a laboratory glucose.
- Take a critical sample during a spontaneous low, or provoke it safely (supervised 72-hour fast or mixed-meal test).
- Read insulin, C-peptide, proinsulin, beta-hydroxybutyrate and the secretagogue screen together.
- Endogenous hyperinsulinism with a negative drug screen: localise the tumour (CT or MRI, endoscopic ultrasound, functional imaging).
Reading the critical sample during hypoglycaemia
| Cause | Insulin | C-peptide | Sulfonylurea screen | Beta-hydroxybutyrate |
|---|---|---|---|---|
| Injected insulin | High | Low | Negative | Low |
| Sulfonylurea or meglitinide | High | High | Positive | Low |
| Insulinoma | High | High | Negative | Low |
| IGF-2-secreting tumour | Low | Low | Negative | Low |
| Starvation, liver failure, adrenal insufficiency | Low | Low | Negative | High |
Keys to the differential
- Alcohol blocks the liver's glucose production: hypoglycaemia after binge drinking can be mistaken for intoxication.
- Older people on sulfonylureas are at high risk: targets are relaxed and drugs with lower hypoglycaemia risk are preferred.
- In infants and young children, hypoglycaemia raises the possibility of inborn errors of metabolism or hormone deficiencies and needs a critical sample too.
Next step / Initial management
- Treat with fast-acting carbohydrate and recheck glucose after about 15 minutes; follow with a meal or snack.
- Sulfonylurea-induced hypoglycaemia: admit and observe because it recurs; octreotide is used when it is refractory.
- Review the diabetes regimen after every severe episode and set safer targets when needed.
- Refer to endocrinology hypoglycaemia in a person without diabetes and recurrent severe hypoglycaemia in diabetes.
Common traps
- A low meter reading after meals proves hypoglycaemia: in a well person with symptoms after meals, the label needs the Whipple triad.
- Blood tests can wait until glucose has been given: by then the critical moment is lost.
- No prescribed sulfonylurea means no sulfonylurea: it can be taken by mistake (a dispensing error) or covertly.
- Sulfonylurea hypoglycaemia can go home once glucose is normal: sulfonylureas act for a long time, especially in kidney failure, so hypoglycaemia recurs; the patient is observed.
- No warning symptoms means no hypoglycaemia: beta-blockers hide the warning symptoms.
Test yourself
Think of the answer, then tap the question to see it.
During hypoglycaemia, a nurse has a high insulin and a very low C-peptide. What is the explanation?
Injected insulin: commercial insulin has no C-peptide, and the high insulin suppresses the patient's own secretion.
High insulin and high C-peptide with a positive sulfonylurea screen: what does this mean?
Hypoglycaemia caused by a sulfonylurea, which makes the beta cells release their own insulin (with its C-peptide).
Why does a person with an insulinoma have a low beta-hydroxybutyrate during hypoglycaemia?
Insulin blocks fat breakdown and ketone production; with inappropriate insulin, ketones stay low even while fasting.
An older man on glibenclamide is found confused with a low glucose and recovers after dextrose. Why not send him home?
Sulfonylureas act for a long time, especially with reduced kidney function, so hypoglycaemia recurs; he needs observation.
Elsewhere in DurgiPedia
Connections
See it in 3D1
The structures of Durgical's 3D anatomy where it is found.
In Pharmacology4
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Hypoglycemia (StatPearls (NCBI Bookshelf), 2022); Non-Diabetic Hypoglycemia (StatPearls (NCBI Bookshelf), 2023); Insulinoma (StatPearls (NCBI Bookshelf), 2025); Factitious Hypoglycemia (StatPearls (NCBI Bookshelf), 2023); Biochemistry, C Peptide (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
